Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous renal replacement therapy (CRRT) is a vital treatment for patients with severe kidney dysfunction that continuously removes fluid and toxins from the bloodstream. Unlike intermittent methods, CRRT provides gentler, more consistent waste removal using the patient's blood pressure or a pump to drive filtration through a specialized filter, which is particularly beneficial for critically ill patients with unstable hemodynamics.

The two main types of CRRT are continuous venovenous hemofiltration (CVVH) and continuous arteriovenous hemofiltration (CAVH). CVVH places a filter between two veins with a pump to achieve higher filtration rates, while CAVH positions a filter between the femoral artery and vein, relying on arterial pressure to drive filtration without requiring an external pump.

The sieving coefficient (S) quantifies a solute's ability to pass through the membrane in CAVH. When S equals one, the drug passes freely through the membrane with complete clearance. When S is less than one, the drug shows partial clearance, with some quantity retained in the plasma, directly affecting the efficacy of drug removal during therapy.

Drug clearance during CRRT equals the sieving coefficient multiplied by the ultrafiltration rate. The amount of drug removed per unit time is calculated as plasma concentration times the unbound fraction times the ultrafiltration rate, allowing clinicians to quantify drug removal and adjust therapy accordingly for optimal patient outcomes.

Both CVVH and CAVH require anticoagulation, commonly with heparin, to prevent clotting within the extracorporeal circuit and maintain therapy efficiency. Maintaining anticoagulation ensures continuity of filtration while preventing filter thrombosis, which would compromise the removal process and necessitate filter replacement during treatment.

Vigilant monitoring during CRRT includes regular assessment of filter function, fluid balance, and electrolyte levels. This continuous surveillance ensures optimal performance and patient safety, allowing clinicians to detect complications early and maintain the stable balance of fluid and electrolytes crucial for critically ill patients.

CVVH maintains hemodynamic stability through its continuous nature, which allows for stable balance of fluid and electrolytes particularly beneficial in critically ill patients. The pump-driven filtration between two veins provides consistent, controlled removal of solutes and fluid without relying on arterial pressure, reducing hemodynamic stress.